Alerts will be sent to your verified email
Verify Email
PREVEST
|
Prevest Denpro
|
Medicamen Biotech
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.02 % | 8.49 % | 18.48 % |
|
5yr average Equity Multiplier
|
1.16 | 1.47 | 1.2 |
|
5yr Average Asset Turnover Ratio
|
0.69 | 0.58 | 0.95 |
|
5yr Avg Net Profit Margin
|
28.95 % | 10.0 % | 16.38 % |
|
Price to Book
|
5.61 | 2.7 | 3.35 |
|
P/E
|
32.51 | 80.94 | 17.95 |
|
5yr Avg Cash Conversion Cycle
|
57.55 Days | 13.14 Days | -16.2 Days |
|
Inventory Days
|
26.01 Days | 66.66 Days | 26.89 Days |
|
Days Receivable
|
50.74 Days | 122.66 Days | 46.84 Days |
|
Days Payable
|
75.73 Days | 257.34 Days | 76.62 Days |
|
5yr Average Interest Coverage Ratio
|
75.33 | 10.36 | 75.84 |
|
5yr Avg ROCE
|
30.18 % | 12.12 % | 24.52 % |
|
5yr Avg Operating Profit Margin
|
36.73 % | 16.84 % | 20.46 % |
|
5 yr average Debt to Equity
|
0.02 | 0.14 | 0.03 |
|
5yr CAGR Net Profit
|
17.49 % | -6.51 % | 11.81 % |
|
5yr Average Return on Assets
|
19.63 % | 5.75 % | 15.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.6 % | 43.16 % | 46.68 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.44 % | 0.95 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |